相似文献
1
[Mycobacterium abscessus subsp. abscessus canaliculitis].
Rev Esp Quimioter. 2021 Apr;34(2):156-157. doi: 10.37201/req/116.2020. Epub 2021 Jan 28.
2
Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.
Intern Med. 2019 Sep 15;58(18):2675-2678. doi: 10.2169/internalmedicine.2391-18. Epub 2019 Jun 7.
3
Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01146-17. Print 2017 Oct.
4
Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
J Med Microbiol. 2018 Jan;67(1):74-82. doi: 10.1099/jmm.0.000661. Epub 2017 Dec 11.
5
Discrepancies between the genotypes and phenotypes of clarithromycin-resistant complex.
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):413-418. doi: 10.5588/ijtld.17.0673.
6
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity .
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0088921. doi: 10.1128/AAC.00889-21. Epub 2021 Aug 30.
7
Epetraborole Is Active against Mycobacterium abscessus.
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0115621. doi: 10.1128/AAC.01156-21. Epub 2021 Jul 19.
8
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01206-17. Print 2017 Nov.
9
Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Complex.
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02234-18. Print 2019 Apr.
10
2-Aminoimidazoles Inhibit Biofilms in a Zinc-Dependent Manner.
Int J Mol Sci. 2022 Mar 9;23(6):2950. doi: 10.3390/ijms23062950.
本文引用的文献
1
Use of MALDI-TOF MS (Bruker Daltonics) for identification of Mycobacterium species isolated directly from liquid medium.
Enferm Infecc Microbiol Clin (Engl Ed). 2021 May;39(5):241-243. doi: 10.1016/j.eimc.2020.05.011. Epub 2020 Jun 12.
2
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
PLoS One. 2015 Jan 12;10(1):e0116236. doi: 10.1371/journal.pone.0116236. eCollection 2015.
3
[Isolation of rapidly growing mycobacteria from samples of skin and soft tissue. An etiology to consider].
Enferm Infecc Microbiol Clin. 2014 Dec;32(10):692-3. doi: 10.1016/j.eimc.2014.03.005. Epub 2014 Oct 16.
4
Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Cornea. 2012 Aug;31(8):900-6. doi: 10.1097/ICO.0b013e31823f8bb9.
5
[Infections due to rapidly growing mycobacteria].
Enferm Infecc Microbiol Clin. 2012 Apr;30(4):192-200. doi: 10.1016/j.eimc.2011.09.017. Epub 2011 Nov 30.
6
Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
J Clin Microbiol. 2011 May;49(5):1790-4. doi: 10.1128/JCM.02135-10. Epub 2011 Mar 16.
7
[Cutaneous and soft skin infections due to non-tuberculous mycobacteria].
Enferm Infecc Microbiol Clin. 2010 Jan;28 Suppl 1:46-50. doi: 10.1016/S0213-005X(10)70008-2.
8
[Microbiological diagnosis of ocular infections].
Enferm Infecc Microbiol Clin. 2009 Nov;27(9):531-5. doi: 10.1016/j.eimc.2009.01.006. Epub 2009 May 1.
Zotero 插件